EV/EBITDA:
-6.88+0.19(+2.69%)Summary
- As of today, RARE EV/EBITDA is -6.88, with a rise of +0.19 (+2.69%) during the most recent trading session on November 19, 2025.
- Over the past year, RARE EV/EBITDA has increased by +2.01 (+22.61%).
- RARE EV/EBITDA is now -83.96% below its all-time high of -3.74.
Performance
RARE EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RARE EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +2.7% | -2.6% | -3.0% |
| 1M1 Month | - | +29.7% | -2.4% |
| 3M3 Months | -1.2% | +9.7% | +9.4% |
| 6M6 Months | +13.7% | -8.1% | -12.0% |
| YTDYTD | +17.7% | -16.3% | -24.3% |
| 1Y1 Year | +22.6% | -21.4% | -29.4% |
| 5Y5 Years | +69.2% | -50.5% | -71.8% |
RARE EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -6.65 | -3.5% | -7.54 | +8.8% |
| 3M | 3-Month | -6.53 | -5.4% | -7.54 | +8.8% |
| 6M | 6-Month | -6.22 | -10.6% | -9.32 | +26.2% |
| 1Y | 1-Year | -6.22 | -10.6% | -9.67 | +28.9% |
| 3Y | 3-Year | -4.10 | -67.8% | -11.20 | +38.6% |
| 5Y | 5-Year | -4.03 | -70.7% | -35.77 | +80.8% |
| All-Time | All-Time | -3.74 | -84.0% | -79.27 | +91.3% |
RARE EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -6.88(+17.7%) |
| 2024 | -8.36(-5.7%) |
| 2023 | -7.91(-46.2%) |
| 2022 | -5.41(+63.6%) |
| 2021 | -14.88(+46.2%) |
| 2020 | -27.64(-456.1%) |
| Date | Value |
|---|---|
| 2019 | -4.97(+0.2%) |
| 2018 | -4.98(+12.9%) |
| 2017 | -5.72(+44.5%) |
| 2016 | -10.30(+61.6%) |
| 2015 | -26.82(-23.9%) |
| 2014 | -21.64 |
FAQ
- What is Ultragenyx Pharmaceutical Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Ultragenyx Pharmaceutical Inc.?
- What is RARE EV/EBITDA year-to-date change?
- What is Ultragenyx Pharmaceutical Inc. EV/EBITDA year-on-year change?
What is Ultragenyx Pharmaceutical Inc. EV/EBITDA?
The current EV/EBITDA of RARE is -6.88
What is the all-time high EV/EBITDA for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high EV/EBITDA is -3.74
What is RARE EV/EBITDA year-to-date change?
Ultragenyx Pharmaceutical Inc. EV/EBITDA has changed by +1.48 (+17.70%) since the beginning of the year
What is Ultragenyx Pharmaceutical Inc. EV/EBITDA year-on-year change?
Over the past year, RARE EV/EBITDA has changed by +2.01 (+22.61%)